DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Laux V, Perzborn E, Kubitza D. et al.
Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Semin Thromb Hemost 2007;
33: 515-523.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.